News
PODD
265.47
-0.79%
-2.12
Analysts’ Top Healthcare Picks: Insulet (PODD), Monte Rosa Therapeutics (GLUE)
TipRanks · 1d ago
Insulet awarded $452M in damages in EOFlow case
Seeking Alpha · 2d ago
Morgan Stanley Sticks to Their Buy Rating for Insulet (PODD)
TipRanks · 2d ago
Insulet Announces On December 3, 2024, After A 4-Week Trial In The U.S. District Court For The District Of Massachusetts In The Manner Of Insulet Corporation Vs. EOFlow Co., A Jury Verdict Was Returned In Favor Of The Company; The Jury Awarded Total Damages Of $452M To The Co
Benzinga · 3d ago
INSULET CORP - JURY AWARDS CO $452M IN DAMAGES
Reuters · 3d ago
Insulet Successfully Defends its Intellectual Property Against EOFlow Co. in U.S. District Court
Barchart · 3d ago
Here's Why Insulet (NASDAQ:PODD) Has Caught The Eye Of Investors
Simply Wall St · 3d ago
Is First Trust Health Care AlphaDEX ETF (FXH) a Strong ETF Right Now?
NASDAQ · 4d ago
Weekly Report: what happened at PODD last week (1125-1129)?
Weekly Report · 5d ago
Leerink Partners Keeps Their Buy Rating on Insulet (PODD)
TipRanks · 11/28 09:25
Peering Into Insulet's Recent Short Interest
Benzinga · 11/27 18:00
Are Wall Street Analysts Predicting Insulet Stock Will Climb or Sink?
Barchart · 11/27 02:58
Should You Invest in the First Trust Health Care AlphaDEX ETF (FXH)?
NASDAQ · 11/26 11:20
JPMorgan updates its U.S. Analyst Focus List – Adds TPR, ALRM, REG
Seeking Alpha · 11/25 18:58
INSULET CORP <PODD.O>: LEERINK PARTNERS RAISES TARGET PRICE TO $290 FROM $278
Reuters · 11/25 12:22
Weekly Report: what happened at PODD last week (1118-1122)?
Weekly Report · 11/25 09:04
U.S. RESEARCH ROUNDUP-Domino's Pizza, Elastic NV, Snowflake
Reuters · 11/25 07:05
PODD Stock to Gain From Launch of Omnipod 5 With Abbott's CGM in US
NASDAQ · 11/22 15:15
Franklin Convertible Securities Fund Q3 2024 Commentary
Seeking Alpha · 11/21 14:59
Insulet: Superb Business Growth, Starting Valuations Outsized Risk
Seeking Alpha · 11/21 12:55
More
Webull provides a variety of real-time PODD stock news. You can receive the latest news about Insulet Corp through multiple platforms. This information may help you make smarter investment decisions.
About PODD
Insulet Corporation is a medical device company. It is primarily engaged in the development, manufacture and sale of its continuous insulin delivery systems for people with insulin-dependent diabetes. The Omnipod System includes the Omnipod 5 Automated Insulin Delivery System (Omnipod 5), the Omnipod DASH Insulin Management System, the Omnipod Insulin Management System, and Omnipod GO. It also produces pods for Amgen for use in the Neulasta Onpro kit, a delivery system for Amgen's Neulasta. The Omnipod platform offers continuous insulin delivery that provides various benefits of insulin pump therapy in a way without the need for external tubing required with conventional pumps. The small, lightweight, self-adhesive disposable tubeless Omnipod device (Pod), can be worn in multiple locations, including the abdomen, hip, back of upper arm, upper thigh, or lower back, and delivers insulin into the body through a small flexible tube. Omnipod 5 includes an AID algorithm embedded in the Pod.